- Filed
- May 10, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 7, 2024 | 2.37M sh |
| Short Term Debt | Q1 2024 · Mar 31, 2024 | $1.26M |
| Short Term Debt | Q1 2024 · Feb 6, 2024 | $1.4M |
| Short Term Debt | Q1 2024 · Dec 31, 2023 | $0 |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $14.1M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $15.29M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $35.35M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $5.08M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $35.44M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $34.29M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $18.48M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $19M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $21.17M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $21.84M |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 1.94M sh |
| Capex | Q1 2024 · Mar 31, 2023 | $535K |
| Operating Cash Flow restated | Q1 2024 · Mar 31, 2023 | −$9.23M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | −$11.03M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | −$6.41M |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | −$2.79 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | −$2.79 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $6.66M |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $3.28M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$5.4M |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$4.95M |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $9.9M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $1.35M |
| Revenue | Q1 2024 · Mar 31, 2023 | $11.25M |